PLA2G12B and type 2 diabetes mellitus: These results suggested that epimedin C could increase the expression levels of Pla2g12b and Apob, promote the secretion of liver VLDL, facilitate lipolysis as well as fat digestion and absorption, reduce the deposition of lipid in livers, and thus alleviate the symptoms of T2DM.